Suzano S.A (SUZ) Fair Value & Analysis
Basic Materials · US · Market cap $9.9B
Suzano S.A
SUZ · US
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 8 days ago
Share price −2.2% over the past month.
Price vs Fair Value (12 months)
12‑month range $7.83 – $11.69 · fair‑value band $14.10 – $60.55 · the $8.04 price screens below the $24.29 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Suzano S.A (SUZ) currently trades at $8.04, while our model-based Fair Value estimate is $24.29 — implying the stock looks roughly 202.1% undervalued today. We read business quality at 46/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Suzano S.A generated revenue of $49.5B at a net margin of 23.0%. Revenue declined 5.1% year over year. It earns a return on equity of 26.3%. Net debt stands at $91.1B. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Suzano S.A. manufactures and sells pulp and paper products in Brazil and internationally. It operates in two segments, Cellulose, and Paper. The company offers coated and uncoated printing and writing papers, paperboards, tissue papers, and market and fluff pulps. It also engages in the research, development, and production of biofuel; operation of port terminals; biotechnology and nanocrystalline pulps research and development activities; power generation and distribution business; road freight transport activities; commercialization of equipment and parts; research and development of lignin; industrialization and commercialization of cellulose, microfiber cellulose, paper, and paperboard products; and industrialization, commercialization, and exporting of pulp products. In addition, the company is involved in the commercial office, corporate venture capital, and financial fundraising activities; production of consumer goods through cellulose-based liquids; development and …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Suzano S.A reported revenue of $49.1B in FY2025 versus $41.0B in FY2021, a compound +4.6%/yr. Reported net income was $13.1B in FY2025, compounding +11.1%/yr from FY2021.
Is SUZ fairly valued? → Check now
Recent news
- Kimberly-Clark’s 80% Payout Ratio: Balance Sheet Says Retirees Shouldn’t Be Scared
- SUZ vs. KLBAY: Which Stock Should Value Investors Buy Now?
- Should Value Investors Buy Suzano (SUZ) Stock?
- Workiva (WK) Holds Resilience Over Market Fears
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
6 more Paper & Paper Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Klabin S.A KLBN11 | R$17.05 | R$12.20 | -28% |
| UPM-Kymmene Oyj UPMKF | $29.33 | $17.60 | -40% |
| Svenska Cellulosa Aktiebolaget SCA (publ) SCAB | kr 100.20 | kr 49.40 | -51% |
| Shandong Sunpaper Co 002078 | ¥13.24 | ¥9.88 | -25% |
| Holmen AB HLMMF | $35.72 | $28.52 | -20% |
| Mondi plc MNODF | $9.70 | $7.32 | -25% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Suzano S.A (SUZ) undervalued?
What is the fair value of SUZ?
What is the quality score of SUZ?
What is the revenue of Suzano S.A (SUZ)?
What is the net profit margin of SUZ?
Does Suzano S.A pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.